标普生物科技LOF(161127)
动态评分： 5.53分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2021-03-31 | MGNX | MacroGenics Inc | 96.13 | 0.68% |
| 2020-12-31 | ALXN | 亚力兄制药 | 98.58 | 1.1% |
| 2020-12-31 | SAGE | Sage Therapeutics Inc | 95.62 | 1.07% |
| 2020-12-31 | IONS | Ionis Pharmaceuticals Inc | 94.18 | 1.05% |
| 2020-12-31 | TGTX | TG Therapeutics Inc | 93.92 | 1.05% |
| 2020-12-31 | KOD | Kodiak Sciences Inc | 89.05 | 1% |
| 2020-12-31 | BBIO | BridgeBio Pharma Inc | 88.44 | 0.99% |
| 2020-12-31 | APLS | Apellis Pharmaceuticals Inc | 87.86 | 0.98% |
| 2020-12-31 | EDIT | Editas Medicine Inc | 86.41 | 0.97% |
| 2020-12-31 | ARNA | Arena Pharmaceuticals Inc | 84.72 | 0.95% |
| 2020-12-31 | BMRN | 拜玛林制药 | 84.17 | 0.94% |
| 2020-12-31 | UTHR | 联合治疗 | 83.49 | 0.93% |
| 2020-12-31 | BTAI | BioXcel Therapeutics Inc | 81.78 | 0.91% |
| 2020-12-31 | EBS | Emergent BioSolutions Inc | 81.73 | 0.91% |
| 2020-12-31 | GBT | 全球血液疗法 | 81.47 | 0.91% |
| 2020-12-31 | INCY | 因塞特医疗 | 81.67 | 0.91% |
| 2020-12-31 | LGND | Ligand Pharmaceuticals Inc | 81.76 | 0.91% |
| 2020-12-31 | NBIX | 神经分泌生物科学 | 81.05 | 0.91% |
| 2020-12-31 | CDNA | CareDx Inc | 80.17 | 0.9% |
| 2020-12-31 | VRTX | 福泰制药 | 80.34 | 0.9% |
公告&资料
